This site is intended for Healthcare Professionals only.

EU lists rare nerve disorder as possible side-effect of AstraZeneca Covid-19 vaccine

Date:

Share post:

Europe’s medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible sideeffect of AstraZeneca‘s Covid19 vaccine, regular safety updates from the watchdog showed on Wednesday.

The European Medicines Agency also tagged some other less severe sideeffects to vaccines from Johnson & Johnson, Moderna as well as AstraZEneca’s shot.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

‘I care deeply about the future of our community pharmacies,’ says Rishi Sunak

The UK prime minister also recognised the need to invest in health infrastructure across the country   Responding to...

DHSC Plans to Allow Hub and Spoke Models Across Different Pharmacy Ownerships Soon

It has decided to proceed with the implementation of the two hub and spoke models that it consulted...

NHS Long Term Workforce Plan: 350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places The government has...

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well...